More Than 1.2m Adverse Drug Reactions Reported In EU In 2016; EMA Reviewed 2,000 Safety Signals
Executive Summary
The European Medicines Agency has published details of the drug safety issues it dealt with in 2016, noting that more than 1.2 million adverse drug reaction reports were received and that it reviewed in excess of 2,000 potential safety signals. A total of 118 products were withdrawn from European markets.
You may also be interested in...
Roadmap To Improve EMA’s Medical Literature Monitoring Service Due Soon
A roadmap to improve the European Medicines Agency’s medical literature monitoring service will be published soon. While some of industry’s suggestions to expand or improve the service have been rejected, many others have either already been implemented or will materialize in the near future.
New EudraVigilance System To Usher In Simplified Reporting of ADRs From Nov. 22
The European Medicines Agency is asking drug companies and EU national competent authorities to prepare for the late November launch of the new EU pharmacovigilance database, which will have enhanced functionalities for reporting and analysing suspected adverse reactions.
Industry & Regulators To Align Advice on COVID-19 Vaccine Updates
A multi-stakeholder workshop looked at the data needed to support updates to vaccine composition and the time required by manufacturers to update their vaccines, change their manufacturing processes and prepare approval applications.